HighTower Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.3M | Sell |
49,020
-16,664
| -25% | -$7.39M | 0.02% | 585 |
|
|
2026
Q1 | $29.3M | Buy |
65,684
+18,125
| +38% | +$8.45M | 0.03% | 498 |
|
|
2025
Q4 | $21.6M | Buy |
47,559
+3,544
| +8% | +$1.53M | 0.02% | 584 |
|
|
2025
Q3 | $17.2M | Sell |
44,015
-12,332
| -22% | -$5.15M | 0.02% | 647 |
|
|
2025
Q2 | $25.1M | Buy |
56,347
+2,722
| +5% | +$1.25M | 0.03% | 502 |
|
|
2025
Q1 | $26M | Buy |
53,625
+5,039
| +10% | +$2.35M | 0.04% | 463 |
|
|
2024
Q4 | $19.6M | Sell |
48,586
-8,656
| -15% | -$4.01M | 0.03% | 534 |
|
|
2024
Q3 | $26.5M | Buy |
57,242
+4,148
| +8% | +$1.99M | 0.04% | 441 |
|
|
2024
Q2 | $24.7M | Sell |
53,094
-4,192
| -7% | -$1.82M | 0.04% | 438 |
|
|
2024
Q1 | $24M | Sell |
57,286
-25,163
| -31% | -$10.6M | 0.04% | 426 |
|
|
2023
Q4 | $33.4M | Sell |
82,449
-6,045
| -7% | -$2.23M | 0.06% | 334 |
|
|
2023
Q3 | $30.7M | Buy |
88,494
+4,553
| +5% | +$1.59M | 0.06% | 325 |
|
|
2023
Q2 | $29.5M | Buy |
83,941
+22,918
| +38% | +$7.72M | 0.06% | 325 |
|
|
2023
Q1 | $19.3M | Sell |
61,023
-2,805
| -4% | -$841K | 0.04% | 415 |
|
|
2022
Q4 | $18.4M | Buy |
63,828
+13,869
| +28% | +$4.23M | 0.04% | 420 |
|
|
2022
Q3 | $14.5M | Sell |
49,959
-7,848
| -14% | -$2.26M | 0.04% | 439 |
|
|
2022
Q2 | $16.3M | Sell |
57,807
-36,502
| -39% | -$9.77M | 0.04% | 406 |
|
|
2022
Q1 | $24.6M | Buy |
94,309
+29,446
| +45% | +$6.99M | 0.05% | 324 |
|
|
2021
Q4 | $14.2M | Buy |
64,863
+11,205
| +21% | +$2.18M | 0.03% | 482 |
|
|
2021
Q3 | $9.69M | Buy |
53,658
+40,274
| +301% | +$7.86M | 0.03% | 544 |
|
|
2021
Q2 | $2.69M | Sell |
13,384
-2,251
| -14% | -$471K | 0.01% | 1068 |
|
|
2021
Q1 | $3.36M | Buy |
+15,635
| New | +$3.43M | 0.01% | 883 |
|
|
2020
Q4 | – | Sell |
-13,185
| Closed | -$3.59M | – | 2873 |
|
|
2020
Q3 | $3.59M | Buy |
13,185
+1,806
| +16% | +$498K | 0.02% | 668 |
|
|
2020
Q2 | $3.31M | Buy |
11,379
+1,410
| +14% | +$382K | 0.02% | 643 |
|
|
2020
Q1 | $2.38M | Sell |
9,969
-193
| -2% | -$44.3K | 0.02% | 693 |
|
|
2019
Q4 | $2.23M | Buy |
10,162
+1,502
| +17% | +$304K | 0.01% | 816 |
|
|
2019
Q3 | $1.47M | Buy |
8,660
+1,958
| +29% | +$346K | 0.01% | 1001 |
|
|
2019
Q2 | $1.23M | Buy |
6,702
+1,170
| +21% | +$205K | 0.01% | 1095 |
|
|
2019
Q1 | $1.01M | Sell |
5,532
-1,366
| -20% | -$252K | 0.01% | 1134 |
|
|
2018
Q4 | $1.14M | Sell |
6,898
-3,383
| -33% | -$586K | 0.01% | 991 |
|
|
2018
Q3 | $1.99M | Buy |
10,281
+3,297
| +47% | +$587K | 0.01% | 838 |
|
|
2018
Q2 | $1.19M | Buy |
6,984
+274
| +4% | +$42.5K | 0.01% | 1049 |
|
|
2018
Q1 | $1.09M | Sell |
6,710
-1,346
| -17% | -$220K | 0.01% | 1034 |
|
|
2017
Q4 | $1.2M | Sell |
8,056
-7,931
| -50% | -$1.17M | 0.01% | 1018 |
|
|
2017
Q3 | $2.43M | Sell |
15,987
-2,988
| -16% | -$450K | 0.02% | 754 |
|
|
2017
Q2 | $2.45M | Buy |
18,975
+588
| +3% | +$70.8K | 0.02% | 725 |
|
|
2017
Q1 | $2.01M | Buy |
18,387
+11,669
| +174% | +$1.03M | 0.02% | 757 |
|
|
2016
Q4 | $495K | Sell |
6,718
-1,836
| -21% | -$149K | 0.01% | 1257 |
|
|
2016
Q3 | $748K | Buy |
8,554
+5,660
| +196% | +$535K | 0.01% | 1045 |
|
|
2016
Q2 | $252K | Sell |
2,894
-3,826
| -57% | -$331K | ﹤0.01% | 1392 |
|
|
2016
Q1 | $532K | Sell |
6,720
-4,348
| -39% | -$393K | ﹤0.01% | 1347 |
|
|
2015
Q4 | $1.4M | Buy |
11,068
+7,514
| +211% | +$907K | 0.02% | 789 |
|
|
2015
Q3 | $369K | Sell |
3,554
-4,173
| -54% | -$536K | ﹤0.01% | 1354 |
|
|
2015
Q2 | $954K | Sell |
7,727
-14,894
| -66% | -$1.88M | 0.02% | 775 |
|
|
2015
Q1 | $2.67M | Sell |
22,621
-8,836
| -28% | -$1.06M | 0.04% | 495 |
|
|
2014
Q4 | $3.74M | Sell |
31,457
-25,550
| -45% | -$2.88M | 0.06% | 357 |
|
|
2014
Q3 | $6.4M | Sell |
57,007
-1,873
| -3% | -$178K | 0.11% | 222 |
|
|
2014
Q2 | $5.58M | Buy |
58,880
+331
| +0.6% | +$23.2K | 0.1% | 230 |
|
|
2014
Q1 | $4.14M | Buy |
58,549
+52,796
| +918% | +$4.18M | 0.08% | 287 |
|
|
2013
Q4 | $427K | Buy |
5,753
+1,155
| +25% | +$80.4K | 0.01% | 1023 |
|
|
2013
Q3 | $349K | Buy |
4,598
+554
| +14% | +$44.1K | 0.01% | 972 |
|
|
2013
Q2 | $324K | Buy |
+4,044
| New | +$298K | 0.01% | 960 |
|
Other funds holding VRTX
HighTower Advisors's VRTX Position: Q2 2026 in Review
HighTower Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 25% in Q2 2026, selling an estimated $7.39M and leaving 49,020 shares worth $24.3M. The position accounts for 0.02% of the portfolio, ranked #585.
HighTower Advisors first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.4M in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- HighTower Advisors held 49,020 shares of Vertex Pharmaceuticals worth $24.3M as of Q2 2026.
- HighTower Advisors sold 16,664 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.39M.
- Vertex Pharmaceuticals made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #585 holding.
- HighTower Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- HighTower Advisors's Vertex Pharmaceuticals position peaked at $33.4M in Q4 2023.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.